Trial intelligence / Profile preview

TRK-820 for Intractable Pruritus in Chronic Liver Disease

NCT00638495Phase 2Completed

Sponsor
Toray Industries
Start
Mar 2008
Primary completion
Dec 2009
Modality
Small Molecules
Countries
1
01

Overview

A Phase 2 trial of nalfurafine in pruritus, sponsored by Toray Industries. Started Mar 2008; status: completed.

02

Drugs

nalfurafine
03

Conditions

pruritus

Beyond the preview

Go deeper on NCT00638495.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00638495.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call